Volume 60, Issue 1, Pages (July 2011)

Slides:

Advertisements

Similar presentations

Volume 56, Issue 5, Pages (November 2009)

Advertisements

Volume 64, Issue 3, Pages (September 2013)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis Maria I. Carlo, Darren R.

Volume 45, Issue 6, Pages (June 2004)

Volume 63, Issue 6, Pages (June 2013)

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Volume 67, Issue 1, Pages (January 2015)

Treatment Strategies in Advanced Prostate Cancer/Genitourinary Malignancies: The Use of Bisphosphonates Across the Continuum John M. Fitzpatrick, Marc.

The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks Marcus G.

Volume 52, Issue 1, Pages (July 2007)

Volume 74, Issue 1, Pages (July 2018)

Volume 51, Issue 1, Pages (January 2007)

Volume 52, Issue 3, Pages (September 2007)

Volume 53, Issue 5, Pages (May 2008)

Volume 74, Issue 2, Pages (August 2018)

Volume 66, Issue 6, Pages (December 2014)

Ziya Kirkali, Hein Van Poppel European Urology

Let the Games Begin (with EAU Approval)

Volume 68, Issue 1, Pages (July 2015)

Volume 72, Issue 5, Pages (November 2017)

Volume 63, Issue 1, Pages (January 2013)

Volume 74, Issue 4, Pages (October 2018)

Volume 52, Issue 1, Pages (July 2007)

Volume 66, Issue 2, Pages (August 2014)

Volume 59, Issue 6, Pages (June 2011)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

Volume 54, Issue 4, Pages (October 2008)

Volume 54, Issue 4, Pages (October 2008)

Volume 73, Issue 2, Pages (February 2018)

Volume 68, Issue 1, Pages 5-7 (July 2015)

Volume 70, Issue 3, Pages (September 2016)

Volume 66, Issue 5, Pages (November 2014)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 68, Issue 1, Pages (July 2015)

Volume 59, Issue 4, Pages (April 2011)

Volume 69, Issue 3, Pages (March 2016)

Volume 60, Issue 5, Pages (November 2011)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Volume 66, Issue 5, Pages (November 2014)

Volume 61, Issue 6, Pages (June 2012)

Volume 64, Issue 4, Pages (October 2013)

Volume 74, Issue 3, Pages (September 2018)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 66, Issue 6, Pages (December 2014)

Volume 51, Issue 5, Pages (May 2007)

Neoplasia of the Kidney—a Rare Event During Pregnancy

Volume 63, Issue 3, Pages (March 2013)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 65, Issue 6, Pages (June 2014)

Tillmann Loch, Pat Fox Fulgham European Urology

Volume 67, Issue 6, Pages (June 2015)

Volume 52, Issue 1, Pages (July 2007)

The Economic Costs of Overactive Bladder in Germany

Volume 50, Issue 5, Pages (November 2006)

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

Volume 66, Issue 6, Pages (December 2014)

European Urology Oncology

Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Shawn S. Groth, MD, MS, Natasha.

Sergio Bracarda European Urology Supplements

European Urology is “Your” Journal

Epidemiology of Renal Cell Carcinoma

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Annika Berntsen, Poul F. Geertsen, Inge Marie Svane European Urology

Volume 67, Issue 4, Pages (April 2015)

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Volume 54, Issue 1, Pages (July 2008)

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Presentation transcript:

Volume 60, Issue 1, Pages 39-44 (July 2011) Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney Cancer Michael A.S. Jewett, Kamal Mattar, Joan Basiuk, Christopher G. Morash, Stephen E. Pautler, D. Robert Siemens, Simon Tanguay, Ricardo A. Rendon, Martin E. Gleave, Darrel E. Drachenberg, Raymond Chow, Hannah Chung, Joseph L. Chin, Neil E. Fleshner, Andrew J. Evans, Brenda L. Gallie, Masoom A. Haider, John R. Kachura, Ghada Kurban, Kimberly Fernandes, Antonio Finelli European Urology Volume 60, Issue 1, Pages 39-44 (July 2011) DOI: 10.1016/j.eururo.2011.03.030 Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 1 Summary of the numbers of patients and tumors entered in the Renal Cell Carcinoma Consortium of Canada-RC4 study, with their outcomes. AS=active surveillance; SRM=small renal mass. European Urology 2011 60, 39-44DOI: (10.1016/j.eururo.2011.03.030) Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 2 Summary of those patients who progressed in the Renal Cell Carcinoma Consortium of Canada-RC4 study, with their outcomes. AML=angiomyolipoma; RCC=renal cell carcinoma. European Urology 2011 60, 39-44DOI: (10.1016/j.eururo.2011.03.030) Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 3 Growth patterns of small renal masses (SRMs) with ≥12 mo of follow-up (151 tumors in 127 patients). The interval observed maximum axial imaged diameter over time for each SRM is subplotted with the overlay of the best fit average growth curves. A mixed-model regression analysis demonstrated an average overall growth rate of 0.13cm/yr (solid line). The average growth rate of those with diagnostic needle core biopsies (46) is represented by the dot dash line for those that were malignant (dot dash line) and the dashed line for those that were benign. European Urology 2011 60, 39-44DOI: (10.1016/j.eururo.2011.03.030) Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 4 Waterfall plot of the change in maximal axial dimension of each small renal mass from trial entry to last follow-up. European Urology 2011 60, 39-44DOI: (10.1016/j.eururo.2011.03.030) Copyright © 2011 European Association of Urology Terms and Conditions